A. S. Paraskar et al. / Tetrahedron Letters 44 (2003) 3305–3308
3307
Scheme 2. Cu2+-activation in three-component coupling for Biginelli reaction.
The results are shown in Table 2. In all cases studied,
the three-component reaction proceeded smoothly to
give the corresponding 3,4-dihydropyrimidin-2(1H)-
ones in high yields. Most importantly, aromatic alde-
R.; Reddy, V. V. N. Tetrahedron Lett. 2002, 43, 2657–
2659; (h) Ramalinga, K.; Vijayalaxmi, P.; Kaimal, T. N.
B. Synlett 2001, 863; (i) Kumar, A. K.; Kasthuraiah, M.;
Reddy, S. C.; Reddy, C. D. Tetrahedron Lett. 2001, 42,
7873–7875; (j) Yadav, J. S.; Reddy, B. V. S.; Srinivas, R.;
Venugopal, C.; Ramalingam, T. Synthesis 2001, 1341–
1345; (k) Bigi, F.; Carloni, S.; Frullanti, B.; Maggi, R.;
Sartori, G. Tetrahedron Lett. 1999, 40, 3465–3468; (l)
Kappe, C. O.; Falsone, S. F. Synlett 1998, 718–720; (m)
Peng, J.; Deng, Y. Tetrahedron Lett. 2001, 42, 5917–5919;
(n) Kidwai, M.; Saxena, S.; Mohan, R.; Venkataramanan,
R. J. Chem. Soc., Perkin Trans. 1 2002, 1845–1846; (o)
Xia, M.; Wang, Y. Tetrahedron Lett. 2002, 43, 7703–7705.
3. Sibi, M. P.; Cook, G. R. In Lewis Acids in Organic
Synthesis; Yamamoto, H., Ed.; Wiley-VCH, New York,
2000; Chapter 12, pp. 543–574.
hydes
carrying
either
electron-donating
or
electron-withdrawing substituents including hydroxy
groups reacted efficiently giving excellent yields. It was
established that the mechanism of this reaction
involves, at first, the formation of activated acylimine 3
so that addition of enolate 4 is facilitated to afford
intermediate 5 which then undergoes facile condensa-
tion to give 3,4-dihydropyrimidin-2(1H)-ones
2
(Scheme 2) [the formation of 3 and 5 was confirmed in
1
our studies by in situ H and 13C NMR experiments in
CD3OD at 25°C].
In conclusion, we describe a simple modification of the
Biginelli 3,4-dihydropyrimidin-2(1H)-one synthesis
using Cu(OTf)2 as a reusable catalyst. Excellent yields,
recycling of the catalyst with negligible loss of activity,
and the application to a variety of substituted/function-
alized aryl aldehydes are some of the salient features of
this reaction. It is noteworthy that many 3,4-dihydro-
pyrimidin-2(1H)-ones 2 and their derivatives are medic-
inally important as calcium channel blockers, antihy-
pertensive agents, a-1a-antagonists and anti-HIV
agents.6
4. General experimental procedure: A 25 ml RB flask was
charged with aldehyde 1a–x (2 mmol), urea (0.120 g, 2
mmol), ethyl acetoacetate (0.260 g, 2 mmol), Cu(OTf)2 ( 7
mg, 1 mol%) and acetonitrile (5 ml). The resulting reaction
mixture was stirred at given temperature in (see Table 2).
After the reaction was complete (monitored by TLC), the
reaction mixture was cooled to room temperature and
filtered through a sintered funnel. The crude product was
further purified by recrystallization (EtOH or iPrOH) to
afford pure 3,4-dihydropyrimidin-2(1H)-ones 2a–x.
5. All the compounds listed in Table 2 were thoroughly
1
characterized by H NMR, FT-IR and MS spectroscopy.
Spectral data for selected new compounds:
Acknowledgements
5-Ethoxycarbonyl-4-(3,4,5-trimethoxyphenyl)-6-methyl-
3,4-dihydropyrimidin-2(1H)-one (2o): mp 180–182°C
(recrystallized from EtOH); IR (THF) 3227, 3102, 2925,
A.S.P. and G.K.D. thank the CSIR, New Delhi, for the
award of Senior Research Fellowship (SRF). The
authors also thank Dr. S. Devotta, Head, Process
Development Division, for his constant encouragement.
2840, 1705, 1646, 1610, 1581, 1512 cm−1 1H NMR (200
;
MHz, DMSO-d6): l 1.13 (t, J=7.0 Hz, 3H), 2.25 (s, 3H),
3.72 (s, 9H), 4.02 (q, J=6.66 Hz, 2H), 5.13 (s, 1H), 6.53 (s,
2H), 7.75 (s, 1H), 9.23 (s, 1H); 13C NMR (200 MHz,
DMSO-d6): l 14.26, 17.87, 54.11, 56.09, 59.40, 60.17,
99.54, 104.03, 140.60, 148.54, 152.55, 152.99, 165.63; MS
m/z (% rel. int.): 350 (M+, 68), 335 (9), 321 (50), 304 (23),
277 (41), 261 (22), 238 (69), 222 (22), 195 (100), 183 (72),
168(23), 155 (45), 137 (75), 125 (52), 110 (40), 77 (32), 66
(41). Anal. calcd for C17H22N2O6: C, 58.27; H, 6.32; N,
7.99. Found: C, 58.32; H, 6.22; N, 8.01%.
References
1. (a) Biginelli, P. Gazz. Chim. Ital. 1893, 23, 360–416; (b)
Kappe, C. O. Tetrahedron 1993, 49, 6937–6963; (c) Kappe,
C. O. Acc. Chem. Res. 2000, 33, 879–888.
2. (a) Hu, E. H.; Sidler, D. R.; Dolling, U. J. Org. Chem.
1998, 63, 3454–3457; (b) Lu, J.; Ma, H. Synlett 2000,
63–64; (c) Lu, J.; Bai, Y.; Wang, L.; Yang, B.; Ma, H.
Tetrahedron Lett. 2000, 41, 9075–9078; (d) Ma, Y; Qian,
C.; Wang, L.; Yang, M. J. Org. Chem. 2000, 65, 3864–
3868; (e) Ranu, B. C.; Hajra, A.; Jana, U. J. Org. Chem.
2000, 65, 6270–6272; (f) Fu, N.; Yuan, Y.; Cao, Z.; Wang,
S.; Wang, J.; Peppe, C. Tetrahedron 2002, 58, 4801–4807;
(g) Reddy, C. V.; Mahesh, M.; Raju, P. V. K.; Babu, T.
5-Ethoxycarbonyl-4-(3-cyclopentoxy-4-methoxyphenyl)-6-
methyl-3,4-dihydropyrimidin-2(1H)-one (2q): mp 185–
188°C (recrystallized from iPrOH); IR (THF) 3225, 3101,
1
2922, 2845, 1707, 1649, 1615, 1580, 1510 cm−1; H NMR
(200 MHz, DMSO-d6): l 1.11 (t, J=8.0 Hz, 3H), 1.70
(m, 9H), 2.26 (s, 3H), 3.74 (s, 3H), 4.01 (q, J=7.33 Hz,
2H), 4.66 (broad, 1H), 5.08 (d, 1H), 6.70–6.90 (m, 3H),
7.68 (s, 1H), 9.16 (s, 1H); 13C NMR (200 MHz,